{
  "id": 17998245,
  "title": "IIPR Q3 2026 slides: life sciences push drives diversification",
  "url": "https://urgent.news/2026/11/03/iipr-q3-2026-slides-life-sciences-push-drives-diversification",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-03T17:50:17.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/company-news/iipr-q3-2026-slides-life-sciences-push-drives-diversification-93CH-4996144"
  },
  "original_language": "en",
  "account": "Innovative Industrial Properties (IIPR) reported its Q3 2026 results on November 3, 2026, highlighting a strategic shift towards life sciences investments while retaining its cannabis real estate focus. The specialized REIT showcased strong performance, with revenue of $64.9 million exceeding analyst estimates. The company's stock rose 1.31% to $55.12, trading within its 52-week range. IIPR's dividend yield is approximately 14%, and its P/E ratio is 12.5. The company aims to reduce concentration risk in the cannabis sector, with life science investments now totaling $545 million, accounting for 20.8% of annualized income. Notable investments include a $100 million revolving credit facility and a $245 million mezzanine loan for a life science campus in Cambridge, Massachusetts. The company's current portfolio is 79% cannabis, but management expects the mix to shift toward life sciences over time.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}